SAB Biotherapeutics Inc. (SABS) Live Share Price, Invest From India

SAB Biotherapeutics Inc. Stock Performance

as on August 11, 2026 at 1:11 am IST

Day's Low
Day's High
$3.78
Day's Price Range
$3.89
$3.85
1.82%
Downside
1.04%
Upside
52 Week's Low
52 Week's High
$1.85
52-Week Price Range
$5.15
$3.85
51.95%
Downside
33.77%
Upside

SAB Biotherapeutics Inc. share price movements today

Previous Close: $3.90
Open: $3.89
Volume: 164.8K
Day's Low - High: $3.78 - $3.89
52 Week Low - High: $1.85 - $5.15

SAB Biotherapeutics Inc. Historical Returns

1 Month Return: + 2.09 %
3 Month Return: -5.11 %
1 Year Return: + 77.27 %
3 Year Return: -51.25 %
5 Year Return: 0 %

SAB Biotherapeutics Inc. Stock Fundamentals & Key Indicators

Check SAB Biotherapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$354.8M

EPS (TTM)

-1.1933

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.60%

PE Ratio (TTM)

16.25

Industry PE ratio

-6.985176470588235

PEG Ratio

EBITDA

-68.7M

Revenue (TTM)

114.7K

Profit Margin

0.00%

Return On Equity TTM

-11.27%

SAB Biotherapeutics Inc. Stock Valuation

Track how SAB Biotherapeutics Inc. P/E has moved over time to understand its valuation trends.

SAB Biotherapeutics Inc. in the last 5 years

Overview
Trends

Lowest (-87.36x)

December 31, 2021

Industry (-6.99x)

August 10, 2026

Today (16.25x)

August 10, 2026

Highest (-0.43x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 16.25x

SAB Biotherapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of SAB Biotherapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
SAB Biotherapeutics Inc.	BUY	$354.8M	NA	16.25	0.00%	NA
Revolution Medicines Inc.	BUY	$44.0B	656.45%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$125.7B	152.5%	28.91	35.00%	NA
Regeneron Pharmaceuticals Inc.	BUY	$80.8B	27.54%	19.42	27.87%	0.47000000000000003%

Stock Returns calculator for SAB Biotherapeutics Inc. Stock including INR - Dollar returns

The SAB Biotherapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

SAB Biotherapeutics Inc. investment value today

Current value as on today

₹1,90,232

Returns

₹90,232

(+90.23%)

Returns from SAB Biotherapeutics Inc. Stock

₹75,000 (+75%)

Dollar Impact

₹15,232 (+15.23%)

Analyst Recommendation on SAB Biotherapeutics Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for SAB Biotherapeutics Inc.. Average target price of $11.64

SAB Biotherapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on SAB Biotherapeutics Inc..

What analysts predicted

66.92%UPSIDE

Target Price

$11.64

Current Price

$3.85

Analyzed by

8 Analysts

Target

$11.64

SAB Biotherapeutics Inc. target price $11.64, a slight upside of 66.92% compared to current price of $3.85. According to 8 analysts rating.

Indian Investors' Interest in SAB Biotherapeutics Inc. Stock

Search interest for SAB Biotherapeutics Inc. Stock has decreased by -2% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 11, 2026 to August 10, 2026

Change:-2% versus previous 30 day period

SAB Biotherapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	0	0	0	0	-	-	-	-	-	-
Gross Profit	-1	0	0	0	-7	0	0	0	0	-
Operating Income	-11	-10	-11	-10	-10	-9	-12	-15	-19	-23
EBITDA	-2	-6	-9	-10	-4	-9	46	-16	-18	-21
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	1	1	0	0	0	0	0	0	0	0
Income Before Tax	-5	-7	-10	-11	-5	-10	45	-16	-18	-22
Income Tax Expense	-13	-	-	13	-	-	-	-	-	-
Net Income	-5	-7	-10	-11	-5	-10	45	-16	-18	-22
Net Profit Margin	-532.06%	-2787.69%	2524246.34%	-9934.52%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

SAB Biotherapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	3	55	60	23	2	1	-
Gross Profit	3	55	59	20	-1	-3	-3
Operating Income	-8	20	-13	-28	-38	-42	-48
EBITDA	-8	21	-15	-15	-38	-28	16
Interest Expense	0	0	0	0	0	0	0
Depreciation	0	0	1	1	3	4	3
Income Before Tax	-8	20	-17	-18	-42	-34	13
Income Tax Expense	0	0	0	0	0	-	-
Net Income	-8	20	-17	-18	-42	-34	13
Net Profit Margin	-261.07%	36.42%	-28.16%	-78.40%	-1884.50%	-2579.03%	0.00%

SAB Biotherapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-7	-10	-11	-5	-10	5	-16	-18	-41
Operating Cash Flow	-7	-6	-9	-7	-7	-13	-16	-14	-24
Investing Cash Flow	11	-1	9	4	5	-129	-1	-65	-70
Financing Cash Flow	0	0	0	0	0	168	0	89	92
Change in Cash	3	-8	0	-3	-1	25	-18	10	-2

SAB Biotherapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	20	-17	-18	-42	-34	13
Operating Cash Flow	10	1	-23	-25	-34	-44
Investing Cash Flow	-12	-10	-2	0	-11	-121
Financing Cash Flow	8	35	1	66	-1	168
Change in Cash	6	26	-24	41	-47	1

Global Institutional Holdings in SAB Biotherapeutics Inc.

Funds	Holdings
RA Capital Management, LLC	5.27%
Tower Research Capital LLC	0.01%
Mccormack Advisors International	0%
Millennium Management LLC	3.63%
The Goldman Sachs Group Inc	0.07%

See all

Insights on SAB Biotherapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 year, SABS stock has moved up by 77.3%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, -410.0 → 114.69K (in $), with an average increase of 100.4% per quarter
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 588.2% return, outperforming this stock by 639.4%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 486.1% return, outperforming this stock by 408.8%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, 45.44M → -22.49M (in $), with an average decrease of 56.1% per quarter

About SAB Biotherapeutics Inc.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.

Organisation	SAB Biotherapeutics Inc.
Headquarters	777 W 41st St., Miami Beach, FL, United States, 33140
Industry	Biotechnology
CEO	Mr. Samuel J. Reich
E-voting on shares	Click here to vote

Key Management of SAB Biotherapeutics Inc.

Name	Title
Dr. Eddie Joe Sullivan Ph.D.	Co-Founder, President & Director
Ms. Catherine DeRose	Vice President of Human Resources
Dr. Carlos N. Carillo M.Sc., Ph.D.	Senior Vice President of Regulatory Affairs
Ms. Angie Parizek	Senior Vice President of Clinical Operations
Ms. Hua Wu Ph.D.	Senior Vice President of Product Development
Mr. Samuel J. Reich	CEO & Director
Ms. Lucy To	Executive VP & CFO
Dr. Christoph Bausch M.B.A., Ph.D.	Executive VP & COO
Dr. Alexandra Kropotova M.B.A., M.D.	Executive VP & Chief Medical Officer
Ms. Cristi Barnett	Vice President of Investor Relations & Corporate Communications

FAQs

What is SAB Biotherapeutics Inc. share price today?

SAB Biotherapeutics Inc. share price today is $3.85 as on August 10, 2026 at 7:41 pm IST. SAB Biotherapeutics Inc. share today touched a day high of $3.89 and a low of $3.78.

What is the 52 week high and 52 week low for SAB Biotherapeutics Inc. share?

SAB Biotherapeutics Inc. share touched a 52 week high of $5.15 on March 12, 2026 and a 52 week low of $1.85 on September 30, 2025. SAB Biotherapeutics Inc. stock price today i.e. August 10, 2026 at 7:41 pm IST is trending at $3.85,which is 25.24% down from its 52 week high and 108.11% up from its 52 week low.

What is SAB Biotherapeutics Inc.'s market capitalisation today?

SAB Biotherapeutics Inc. market capitalisation is $0.00T as on August 10, 2026 at 7:41 pm IST.

How to invest in SAB Biotherapeutics Inc. Stock (SABS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for SAB Biotherapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in SAB Biotherapeutics Inc. Shares that will get you 0.3896 shares as per SAB Biotherapeutics Inc. share price of $3.85 per share as on August 10, 2026 at 7:41 pm IST.

What is the minimum amount required to buy SAB Biotherapeutics Inc. Stock (SABS) from India?

Indian investors can start investing in SAB Biotherapeutics Inc. (SABS) shares with as little as ₹95.29 or $1 (as of August 10, 2026 at 7:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.90 in SAB Biotherapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on August 10, 2026 at 7:41 pm IST). Based on SAB Biotherapeutics Inc. share’s latest price of $3.85 as on August 10, 2026 at 7:41 pm IST, you will get 2.5974 shares of SAB Biotherapeutics Inc.. Learn more about fractional shares .